Study shows Zoloft, combined with therapy effective for childhood anxiety
CHICAGO A study has found that when combined with three months of therapy, the antidepressant Zoloft helped children with anxiety disorders.
Zoloft (sertraline), made by Pfizer and available from numerous generic drug makers, worked best when combined with therapy, though the drug and therapy each worked well on their own as well.
The study involved 488 children aged 7 to 17 randomly assigned to one of four treatments: up to 200 mg a day of the drug alone; 14 one-hour therapy sessions alone; the drug and therapy; or placebo. Among children receiving both therapies, 81 percent had significant improvement after three months, while 60 percent of those receiving therapy alone had improvements, compared to 55 percent of those taking only the drug and 24 percent of those taking placebo.
The study received funding from the National Institutes of Health and was published online in the New England Journal of Medicine.
Walgreens announces promotions of several execs
DEERFIELD, Ill. Seven Walgreens executives received promotions Wednesday.
Carlo Baldan, a category manager for the sleep, pain and incontinence categories, was promoted to divisional merchandising manager for personal care in the retail pharmacy chain’s beauty and fashion division.
Robert Tompkins, the divisional merchandising manager for OTC drugs, was promoted to general merchandising manager of the health and wellness purchasing group, succeeding Chong Bang, who is now vice president of customer-centric retailing. Bob Cinq-Mars will replace Tompkins as divisional merchandise manager for OTC categories including medications for pain, sleep, incontinence, nutrition, diet and smoking cessation.
Robert Bobber, the divisional merchandise manager for consumables, will be in charge of OTC categories that Cinq-Mars previously managed. Robin Randolph, divisional merchandise manager for electronics, will take over for Bobber while maintaining her current position.
Scott Minger, associate category manager for vitamins, has been promoted to category manager for vitamins.
Lannett Co. announces patent approval for generic pain drugs
PHILADELPHIA Generic drug maker Lannett Company announced earlier this month that the United States Patent and Trademark Office granted a patent to subsidiary Cody Laboratories for a method for preparing hydromorphone and hydrocodone.
“Our patented method for preparing hydromorphone and hydrocodone will greatly enhance our ability to manufacture these products quickly and efficiently,” Lannett president and chief executive Arthur Bedrosian said. “Importantly, with minimal incremental investment, the faster manufacturing time appreciably expands our manufacturing capacity, allowing us to maximize our production assets.”
Hydromorphone and hydrocodone are opiate-derived drugs used for treating pain.